SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Overview of attention for article published in Journal of Thoracic Oncology, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 8 news stories from 8 outlets.

"As an organization committed to breaking barriers and saving lives, we are proud to present Prof.

SOURCE GO2 Foundation for Lung Cancer GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress…

SOURCE GO2 Foundation for Lung Cancer GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress…

GO2 Foundation for Lung Cancer (a merger of the Lung Cancer Alliance and the Bonnie J.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.